The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary phase 2 results of PT-112 monotherapy in late-line metastatic castration-resistant prostate cancer (mCRPC).
 
Alan Bryce
Employment - City of Hope
Leadership - City of Hope
Honoraria - Astellas Pharma; Bayer; Bayer; Janssen; Janssen Oncology; Lantheus Medical Imaging; Lilly; MOMA Therapeutics; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Tolmar; Verity Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma
Travel, Accommodations, Expenses - Bayer; Pfizer; Pfizer (Inst); Tolmar
 
Karim Fizazi
Honoraria - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Novartis (Inst)
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo Europe GmbH (Inst); Janssen Oncology (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Janssen; MSD; Novartis; Pfizer
 
Guilhem Roubaud
Honoraria - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen-Cilag (Inst)
Consulting or Advisory Role - AAA/Endocyte/Novartis (Inst); Astellas Pharma; AstraZeneca (Inst); Bayer (Inst); Ipsen (Inst); Janssen-Cilag; Merck/Pfizer (Inst); Pfizer (Inst)
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen-Cilag
 
Scott Tagawa
Stock and Other Ownership Interests - Convergent Therapeutics
Consulting or Advisory Role - 4D Pharma; Abbvie; AIkido Pharma; Ambrx; Amgen; Astellas Pharma; Bayer; Bicycle Therapeutics; Blue Earth Diagnostics; Boston Scientific; Clarity Pharmaceuticals; Clovis Oncology; Convergent Therapeutics; Daiichi Sankyo; Dendreon; Endocyte; Exelixis; Genentech; General Electric; Genomic Health; Gilead Sciences; Hookipa Pharma; Immunomedics; Janssen; Karyopharm Therapeutics; Lantheus Medical Imaging; Medivation; Merck; Myovant Sciences; Novartis; Pfizer; POINT Biopharma; QED Therapeutics; Regeneron; Sanofi; Seagen; Telix Pharmaceuticals; Tolmar; TransThera Biosciences
Research Funding - Abbvie (Inst); Ambrx (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clarity Pharmaceuticals (Inst); Clovis Oncology (Inst); Dendreon (Inst); Endocyte (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Janux Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); POINT Biopharma (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst); Telix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patent Royalty from Immunomedics / Gilead
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Immunomedics; Merck; Sanofi; Telix Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - ATLAB Pharma; Phosplatin Therapeutics
 
Alice Bernard-Tessier
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bouchara Recordati; Janssen; MSD; Novartis (Inst); Orion Clinical; Roche
Travel, Accommodations, Expenses - AAA/Endocyte/Novartis; Bayer; Orion Clinical
 
Diego Teyssonneau
Consulting or Advisory Role - Merck
Speakers' Bureau - Astellas Pharma; Janssen; Merck
Travel, Accommodations, Expenses - Janssen; MSD; Recordati
 
Carole Helissey
Honoraria - Accord Healthcare; Astellas Pharma; AstraZeneca; Bayer; BMSi; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; Viatris
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMSi; Janssen; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Janssen; Pfizer
 
Tanya Dorff
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Novartis; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Hookipa Biotech (Inst); Janssen Oncology (Inst); Promontory Therapeutics (Inst)
 
Dana Rathkopf
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Celgene; Genentech; Janssen; Myovant Sciences; Novartis; Promontory
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Novartis (Inst); Promontory Therapeutics (Inst)
 
Nabil Adra
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation; EMD Serono; Exelixis; Merck; Sanofi
Research Funding - Exelixis (Inst); Genentech (Inst); Merck (Inst); Natera (Inst)
 
Joseph O'Donnell
Employment - Promontory Therapeutics
Leadership - Promontory Therapeutics
Stock and Other Ownership Interests - Promontory Therapeutics
 
Johan Baeck
Employment - Jounce Therapeutics; Promontory Therapeutics
Leadership - Promontory Therapeutics
Stock and Other Ownership Interests - Promontory Therapeutics
Travel, Accommodations, Expenses - Promontory Therapeutics
Other Relationship - Promontory Therapeutics
 
Tyler Ames
Employment - Promontory Therapeutics
Stock and Other Ownership Interests - Promontory Therapeutics
Patents, Royalties, Other Intellectual Property - I am an inventor on some patents pertaining to the mechanism or use of PT-112, an anticancer compound being developed by my employer Promontory Therapeutics.
Travel, Accommodations, Expenses - Promontory Therapeutics
 
Matthew Price
Employment - Promontory Therapeutics
Leadership - Promontory Therapeutics
Stock and Other Ownership Interests - Promontory Therapeutics
Patents, Royalties, Other Intellectual Property - US Patents 10,668,080 and 11,438,619 assigned to Promontory Therapeutics
Travel, Accommodations, Expenses - Promontory Therapeutics
 
Howard Scher
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - AIQ Global; Bayer; Genzyme; Janssen Research & Development; Novartis; Pfizer; Promontory Therapeutics; Regeneron; WIRB-Copernicus Group
Research Funding - AIQ Solutions (Inst); Astrin Biosciences (Inst); Biodesix (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - Elucida Oncology - Intellectual Property Rights
Travel, Accommodations, Expenses - Bayer; Biodesix; Epic Sciences; Promontory Therapeutics; Prostate Cancer Foundation; WIRB-Copernicus Group